research on architectural competence in pharmaceutical firms suggests that

Browse Econ Literature

Working papers
Software components
Book chapters
JEL classification

More features

Subscribe to new research

RePEc Biblio

Author registration.

Economics Virtual Seminar Calendar NEW!

Measuring Competence? Exploring Firm Effects in Pharmaceutical Research

Author & abstract
Download & other version
20 References
488 Citations
Most related
Related works & more

Corrections

Rebecca Henderson
Iain Cockburn
Iain M. Cockburn

Suggested Citation

Download full text from publisher, other versions of this item:, references listed on ideas.

Follow serials, authors, keywords & more

Public profiles for Economics researchers

Various research rankings in Economics

RePEc Genealogy

Who was a student of whom, using RePEc

Curated articles & papers on economics topics

Upload your paper to be listed on RePEc and IDEAS

New papers by email

Subscribe to new additions to RePEc

EconAcademics

Blog aggregator for economics research

Cases of plagiarism in Economics

About RePEc

Initiative for open bibliographies in Economics

News about RePEc

Questions about IDEAS and RePEc

RePEc volunteers

Participating archives

Publishers indexing in RePEc

Privacy statement

Found an error or omission?

Opportunities to help RePEc

Get papers listed

Have your research listed on RePEc

Open a RePEc archive

Have your institution's/publisher's output listed on RePEc

Get RePEc data

Use data assembled by RePEc

Academia.edu no longer supports Internet Explorer.

To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser .

Enter the email address you signed up with and we'll email you a reset link.

We're Hiring!
Help Center

Measuring competence? Exploring firm effects in pharmaceutical research

1995, Long Range Planning

Related Papers

The Journal of Industrial Economics

Iain Cockburn

The RAND Journal of Economics

Journal of Health Economics

Journal of Industrial Economics

Lionel Nesta

Research Policy

Ludovic Dibiaggio

Journal of Economics <html_ent glyph="@amp;" ascii="&"/> Management Strategy

Strategic Management Journal

Brian Silverman

Routledge Studies in the Modern World Economy

Fabio Pammolli

RELATED PAPERS

Journal of Engineering and Technology Management

Laura Cardinal

Jeffrey L Furman

SSRN Electronic Journal

Kwanghui Lim

Organization Science

D. Hsu , Kwanghui Lim

Industrial and Corporate …

Sarah Kaplan

Muthukumar Sangeetha

Hanna Hottenrott

Ashish Arora , Sharon Belenzon

vincent Mangematin

Duane Ireland

Kevin Steensma , Corey Phelps

Luigi Orsenigo

R&D Management

Leonard Jessup

SPRU Electronic Working Paper Series

International Journal of Industrial Organization

Carmine Ornaghi

Bruce Kogut

Advances in Strategic Management: Collaboration and Competition in Business Ecosystems

Innovation, growth and …

Joanna Chataway

Michael Lenox

Strategic management journal

Darko Milosevic

Journal of Management

Antonio Capaldo , Dovev Lavie

Alvaro Escribano , A. Fosfuri

Stuart Graham

Lois M Shelton , Annetta Fortune

Atul Nerkar

Jerome Hauser

Journal of Management Studies

Gerard George

Journal of Economic Behavior & Organization

Shantanu Dutta

Journal of Financial Economics

Daniel Rodriguez

Erkko Autio

BAM 2015: 29th Annual Conference of the British Academy of Management

Bhawani Bhatnagar , Viktor Dörfler , Jill Macbryde

Paola Criscuolo

Kimberly K Merriman

International Journal of Technology Management

Gino Cattani

6 Measuring Competence? Exploring Firm Effects in Drug Discovery

Published: November 2001
Cite Icon Cite
Permissions Icon Permissions

The chapter explores the role of ‘competence’ in pharmaceutical research. It provides support for the existence of sources of heterogeneity highlighted by the resource‐based view of the firm by showing that the large proportion of the variance in research productivity across firms could be attributed to firm‐specific effects. Drawing on detailed qualitative data about the history of research at each of the firm in the sample, a variety of measures of ‘competence’ was constructed. The result of the analysis suggests that ‘architectural competence’, as captured by indicators of the firm's ability to knowledge integrativity, is positively associated with research productivity. Besides that, it is shown that firms that maintain links to the wider scientific community through the use of publication in the open literature as a criterion of promotion, and firms that manage the allocation of key research resources through collaborative rather than dictatorial processes are significantly more productive in drug discovery.

Signed in as

Institutional accounts.

GoogleCrawler [DO NOT DELETE]
Google Scholar Indexing

Personal account

Sign in with email/username & password
Get email alerts
Save searches
Purchase content
Activate your purchase/trial code

Institutional access

Sign in with a library card Sign in with username/password Recommend to your librarian
Institutional account management
Get help with access

Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:

IP based access

Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.

Sign in through your institution

Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institutionâ€™s website and Oxford Academic.

Click Sign in through your institution.
Select your institution from the list provided, which will take you to your institution's website to sign in.
When on the institution site, please use the credentials provided by your institution. Do not use an Oxford Academic personal account.
Following successful sign in, you will be returned to Oxford Academic.

If your institution is not listed or you cannot sign in to your institutionâ€™s website, please contact your librarian or administrator.

Sign in with a library card

Enter your library card number to sign in. If you cannot sign in, please contact your librarian.

Society Members

Society member access to a journal is achieved in one of the following ways:

Sign in through society site

Many societies offer single sign-on between the society website and Oxford Academic. If you see â€˜Sign in through society siteâ€™ in the sign in pane within a journal:

Click Sign in through society site.
When on the society site, please use the credentials provided by that society. Do not use an Oxford Academic personal account.

If you do not have a society account or have forgotten your username or password, please contact your society.

Sign in using a personal account

Some societies use Oxford Academic personal accounts to provide access to their members. See below.

A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.

Some societies use Oxford Academic personal accounts to provide access to their members.

Viewing your signed in accounts

Click the account icon in the top right to:

View your signed in personal account and access account management features.
View the institutional accounts that are providing access.

Signed in but can't access content

Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.

For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.

Our books are available by subscription or purchase to libraries and institutions.

About Oxford Academic
Publish journals with us
University press partners
What we publish
New features
Open access
Rights and permissions
Accessibility
Advertising
Media enquiries
Oxford University Press
Oxford Languages
University of Oxford

Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide

Cookie settings
Cookie policy
Privacy policy
Legal notice

This Feature Is Available To Subscribers Only

This PDF is available to Subscribers Only

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

IMAGES

Pharmaceutical Business Architecture Examples
Importance of Research in Architecture
Architectural Research Methods by David Wang
Benefits of Data analytics in pharmaceutical companies that drive
Pharmaceutical Industries Factory
Pharmaceutical Business Architecture Framework and Examples

VIDEO

WEBINAR: Artificial Intelligence in Practice: How Medical Affairs Can Leverage AI Today
competence firms media(4)
Government issues marketing code for pharmaceutical firms #shorts #currentaffairs #short
CPD in 43
Comprehensive Analysis of Quality Management in Pharmaceutical Manufacturing Process
Day 1: Design of Experiments in Pharmaceutical Research & Development A Primer for Academia

COMMENTS

MGMT CH 5, Product Differentiation Flashcards
5.6 Research and Development (HL) 19 terms. alessiaduchini. Preview. MKT Exam 3. 88 terms. amdani13. ... Research on architectural competence in pharmaceutical firms suggests that. not only do some firms possess this competence, but also that other firms do not and firms without this competence have, on average, been unable to develop it. ...
Ch 5 Quiz Flashcards
Research on architectural competence in pharmaceutical firms suggests that. not only do some firms possess this competence, but also that other firms do not and firms without this competence have, on average, been unable to develop it. ... Recent research suggests that _____ firms must have competitive levels of cost to survive.
Measuring Competence? Exploring Firm Effects in Pharmaceutical Research
Renewed interest in the resource-based theory of the firm has focused attention on the role of heterogeneous organizational 'competence' in competition. This paper attempts to measure the importance of these effects in the context of pharmaceutical research. We distinguish between 'component' and 'architectural' competence, and using internal ...
Measuring Competence? Exploring Firm Effects in Pharmaceutical Research
This paper attempts to measure the importance of these effects in the context of pharmaceutical research. We distinguish between 'component' and 'architectural' competence, and using internal firm data at the program level from 10 major pharmaceutical companies show that together the two forms of competence appear to explain a ...
Measuring competence?: exploring firm effects in pharmaceutical research
This paper distinguishes between 'component' and 'architectural' competence, and using internal firm data at the program level from 10 major pharmaceutical companies shows that together the two forms of competence appear to explain a significant fraction of the variance in research productivity across firms. Renewed interest in the resource-based theory of the firm has focused ...
Measuring Competence? Exploring Firm Effects in Drug Discovery
We adopt a competence-based perspective of the firm for our analysis and contribute to the academic community a way to operationalize the measurement of organizational competencies through using ...
Competencies and Imitability in the Pharmaceutical Industry: An
Current marketing literature, based on resource-based theory, suggests that a firm's marketing competency will have a direct influence on performance (Day, 1994; Hunt & Morgan, 1995; Mooreman & Slotegraaf, 1999). In the pharmaceutical industry, the deployment of strong marketing capabilities impacts the success of new drugs.
MGT 3830: Exam 2
Research on architectural competence in pharmaceutical firms suggests that not only do some firms possess this competence, but that other firms do not; firms without this competence have, on average, been able develop it with minimal investment.
Research on architectural competence in pharmaceutical firms suggests
Research on architectural competence in pharmaceutical firms suggests that A) not only do some firms possess this competence, but that other firms do not; firms without this competence have, on average, been able develop it with minimal investment.
PDF Introduction
the firm effect identified in our previous work, in both firm level and research program level data. "Architectural competence", as captured by our indicators of the firm's ability to knowledge integratively, is positively associated with research productivity. Firms which maintain links to the
Measuring Competence? Exploring Firm Effects in Pharmaceutical Research
This paper attempts to measure the importance of these effects in the context of pharmaceutical research. We distinguish between 'component' and 'architectural' competence, and using internal firm data at the program level from 10 major pharmaceutical companies show that together the two forms of competence appear to explain a ...
An empirical analysis of sustained advantage in the U.S. pharmaceutical
The authors test a model of the relationships among firm resources, firm capabilities, and sustained competitive advantage between 1971 and 1989 and suggest important managerial implications in the way firms coordinate and combine their assets so as to achieve sustainedcompetitive advantage. The authors test a model of the relationships among firm resources, firm capabilities, and sustained ...
Measuring Competence? Exploring Firm Effects in Pharmaceutical Research
Downloadable! Renewed interest in the resource‐based theory of the firm has focused attention on the role of heterogeneous organizational 'competence' in competition. This paper attempts to measure the importance of these effects in the context of pharmaceutical research. We distinguish between 'component' and 'architectural' competence, and using internal firm data at the ...
[PDF] Firm Size and Research Productivity in Drug Discovery . Revised
Corpus ID: 40099154. Firm Size and Research Productivity in Drug Discovery . Revised Jan 1997. R. Henderson, I. Cockburn. Published 2001. Business, Economics, Medicine. TLDR. This research was funded by four pharmaceutical companies and by the Sloan Foundation, and the conclusions and opinions expressed in this paper are the authors' own. Expand.
Strat 5700 Ch. 5 Flashcards
Research on architectural competence in pharmaceutical firms suggests that. not only do some firms possess this competence, but also that other firms do not and firms without this competence have, on average, been unable to develop it ... Recent research suggests that _____ firms must have competitive levels of cost to survive. Product ...
Measuring competence? Exploring firm effects in pharmaceutical research
Similarly the work of Henderson and Clark (1990), Christensen (1992) and Iansiti (1993) suggests that in turbulent environments firms that systematically revisit the 'architectural' Prior research on the pharmaceutical industry These hypotheses are broadly consistent with much of the prior research that has explored the determinants of ...
Measuring competence? Exploring firm effects in pharmaceutical research
Measuring competence? Exploring firm effects in pharmaceutical research
Measuring Competence? Exploring Firm Effects in Drug Discovery
This chapter explores the role of 'competence' in pharmaceutical research. In 'Scale, Scope and Spillovers: The Determinants of Research Productivity in Drug Discovery' (Henderson and Cockburn (), hereafter 'Scale, Scope and Spillovers') we drew upon detailed qualitative and quantitative data obtained from ten major pharmaceutical firms at the programme level to show that large ...
COB 487 Test 1 Flashcards
The ability to use organization structure to facilitate coordination among scientific disciplines to conduct research is known as architectural competence. True. ... Research on architectural competence in pharmaceutical firms suggests that. not only do some firms possess this competence, but also that other firms do not and firms without this ...
Technological Innovation in the Pharmaceutical Industry: The Use of
The results show that input, behavior, and output control enhanced radical innovation, and input and output controls enhanced incremental innovation in a sample of 57 pharmaceutical firms. The literature on the management of R&D professionals strongly advocates managing R&D projects on a project-by-project basis. This literature suggests that projects should be managed differently depending ...
CHAPTER 5 U of U STRAT 5700 Flashcards
Research on architectural competence in pharmaceutical firms suggests that... not only do some firms possess this competence, but also that other firms do not and firms without this Which of the following bases of product differentiation is generally viewed as the most difficult to duplicate?
Publicly Funded Science and the Productivity of the Pharmaceutical Industry
The impact of these huge expenditures on the technological performance of the pharmaceutical industry is evaluated and it is concluded that the returns from publicly funded research have been large, and may be growing even larger. U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the ...
The Changing Structure Of The Pharmaceutical ...
Underlying trends in R&D pro- ductivity are difficult to extract from these indicators, and the apparent decline they suggest could be partly, if not entirely, a mirage. Rising research and development (R&D) expenditures by pharmaceutical com- panies are, in part, a consequence of changing industry structure, particularly the rise of the biotechnology sector. The creation of a market for ...